OncoK9 now available in Asia

Ermolaev Alexandr/stock.adobe.com

PetDx announced that its OncoK9 test for dogs is now available at veterinary clinics in Hong Kong, Singapore, Malaysia, South Korea, and Cambodia through Asia Veterinary Diagnostics Powered by Antech. This expansion for PetDx is the first time the OncoK9 test is available outside of North America.

"Expanding access to this groundbreaking test is a top priority for us. We're eager to provide this powerful tool to pet parents overseas, beginning with veterinary clinics served by Asia Veterinary Diagnostics," said Lauren Holtvoigt, DVM, MBA, vice president of business development at PetDx, in an organizational release.

According to the release,¹ OncoK9 is the first and only liquid biopsy test to detect cancer-associated genomic alternations in canines and can detect 30 different types of canine cancer by drawing blood. The test can be used as an annual screening for dogs that have a high cancer risk due to age, breed, etc. It can also be used to aid in-diagnosis of dogs where cancer is suspected based on either clinical signs or findings.

"Veterinarians and pet parents are profoundly excited to have the capability for non-invasive early cancer detection in dogs," said Andi Flory, DVM, DACVIM (Oncology), Chief Medical Officer at PetDx, and dvm360’s oncology winner for the 2022 Veterinary Heroes™ Awards.

Reference

OncoK9, the Pioneering Blood-Based Early Cancer Detection Test for Dogs, Now Available in Asia Through Asia Veterinary Diagnostics. News release. PetDx. October 26, 2022. Accessed October 26, 2022. https://prnmedia.prnewswire.com/news-releases/oncok9-the-pioneering-blood-based-early-cancer-detection-test-for-dogs-now-available-in-asia-through-asia-veterinary-diagnostics-301659283.html